Journal of Convergence for Information Technology (융합정보논문지)

Convergence Society for SMB (중소기업융합학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Clinical Usefulness of Gamma Glutamyl Transferase as a Surrogate Marker for Metabolic Syndrome in Non Obese Adult Men

비만하지 않은 성인 남성에서 대사증후군의 대리 표지자로서 감마 글루타밀 전이효소의 임상적 유용성 평가

  • Shin, Kyung-A (Dept. of Clinical Laboratory Science, Shinsung University) ;
  • Kim, Eun Jae (Dept. of Obstetrics and Gynecology, Seoul National University)
  • 신경아 (신성대학교 임상병리과) ;
  • 김은재 (서울대병원 의학연구혁신센터 산부인과)
  • Received : 2020.11.12
  • Accepted : 2020.12.20
  • Published : 2020.12.28
Download PDF
⟨ Previous Next ⟩

Abstract

This study was to evaluate the usefulness of gamma glutamyl transferase (GGT) as a surrogate marker predicting metabolic syndrome. 7,155 non obese men over the age of 20 were studied as subjects. The criteria for diagnosing MetS were the National Cholesterol Education Program - Third Adult Treatment Panel (NCEP-ATP III). The risk of developing MetS according to GGT was conducted logistic regression analysis, and the ROC (receiver operating characteristic) curve was obtained to confirm GGT ability to predict the risk of MetS. Regardless of age and body mass index, MetS had a 7.09 times higher risk of onset in the fourth quartile than in the first quartile of GGT (p<0.001). The AUC (area under the curve) of GGT for the diagnosis of MetS was 0.715, and the cutoff value of GGT was 40.0 U/L, the sensitivity was 65.0%, and the specificity was 70.2%. Therefore, GGT is considered to be a useful diagnostic index for diagnosing MetS.

본 연구는 대사증후군을 예측하는 대리 표지자로서 감마 글루타밀 전이효소(gamma glutamyl transferase, GGT)의 유용성을 평가하고자 하였다. 20세 이상의 비만하지 않은 남성 7,155명을 연구대상자로 하였다. 대사증후군 진단기준은 NCEP-ATP III (National Cholesterol Education Program - Third Adult Treatment Panel) 기준을 적용하였다. GGT에 따른 대사증후군 발병 위험도는 로지스틱 회귀분석을 적용하였으며, GGT의 대사증후군 위험 예측능력을 확인하기 위해 ROC (receiver operating characteristic) 곡선을 구하였다. 연령과 체질량지수와 무관하게 GGT 1사분위수보다 4사분위수에서 대사증후군 발병위험이 7.09배 높게 나타났다(p<0.001). 대사증후군 진단을 위한 GGT의 곡선아래면적(area under the curve)은 0.715였으며, GGT의 절단값(cut-off value)은 40.0 U/L, 민감도는 65.0%, 특이도 70.2%로 나타났다. 따라서 GGT는 대사증후군을 진단하기 위한 유용한 진단 지표로 판단된다.

Keywords

References

  1. G. Ndrepepa & A. Kastrati. (2016). Gamma-glutamyl transferase and cardiovascular disease. Annals of Translational Medicine, 4(24), 481. DOI : 10.21037/atm.2016.12.27
  2. J. B. Whitfield. (2001). Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences, 38(4), 263-355. DOI : 10.1080/20014091084227
  3. G. Wannamethee, S. Ebrahim & A. G. Shaper. (1995). Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. American Journal of Epidemiology, 142(7), 699-708. DOI : 10.1093/oxfordjournals.aje.a117699
  4. D. J. Kim et al. (2005). Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabetic Medicine, 22(9), 1134-1140. DOI : 10.1111/j.1464-5491.2005.01581.x
  5. I. Abete, E. Goyenechea, M. A. Zulet & J. A. Martinez. (2011). Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutrition, Metabolism & Cardiovascular Diseases, 21(Suppl 2), B1-B15. DOI : 10.1016/j.numecd.2011.05.001
  6. C. K. Roberts, R. J. Barnard, R. K. Sindhu, M. Jurczak, A. Ehdaie & N. D. Vaziri. (2006). Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism, 55(7), 928-934. DOI : 10.1016/j.metabol.2006.02.022
  7. E. M. Alissa. (2018). Relationship between serum gamma-glutamyltransferase activity and cardiometabolic risk factors in metabolic syndrome. Journal of Family Medicine and Primary Care, 7(2), 430-434. DOI : 10.4103/jfmpc.jfmpc_194_17
  8. D. E. Laaksonen, H. M. Lakka, L. K. Niskanen, G. A. Kaplan, J. T. Salonen & T. A. Lakka. (2002). Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology, 156(11), 1070-1077. DOI : 10.1093/aje/kwf145
  9. B. Isomaa et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4), 683-689. DOI : 10.2337/diacare.24.4.683
  10. V. Regitz-Zagrosek, E. Lehmkuhl & M. O. Weickert. (2006). Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology, 95(3), 136-147. DOI : 10.1007/s00392-006-0351-5
  11. J. Lu et al. (2017). Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance. Journal of Clinical Endocrinology and Metabolism, 102(2), 507-515. DOI : 10.1210/jc.2016-2477
  12. I. Lemieux et al. (2001). Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, Thrombosis, and Vascular Biology, 21(6), 961-967. DOI : 10.1161/01.atv.21.6.961
  13. J. Lugrin, N. Rosenblatt-Velin, R. Parapanov & L. Liaudet. (2014). The role of oxidative stress during inflammatory processes. Biological Chemistry, 395(2), 203-230. DOI : 10.1515/hsz-2013-0241
  14. M. Hamaguchi et al. (2005). The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Annals of Internal Medicine, 143(10), 722-728. DOI : 10.7326/0003-4819-143-10-200511150-00009
  15. J. Hung, B. M. McQuillan, P. L. Thompson & J. P. Beilby. (2008). Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. International Journal of Obesity (Lond), 32(5), 772-779. DOI : 10.1038/sj.ijo.0803793
  16. M. Franzini et al. (2017). Association between plasma gamma-glutamyltransferase fractions and metabolic syndrome among hypertensive patients. Scientific Reports, 7(1), 12003. DOI : 10.1038/s41598-017-12356-w
  17. M. Lafontan & N. Viguerie. (2006). Role of adipokines in the control of energy metabolism: focus on adiponectin. Current Opinion in Pharmacology, 6(6), 580-585. DOI :10.1016/j.coph.2006.08.002
  18. L. Tao et al. (2013). Association between γ-glutamyl transferase and metabolic syndrome: a cross-sectional study of an adult population in Beijing. International Journal of Environmental Research and Public Health, 10(11), 5523-5540. DOI : 10.3390/ijerph10115523
  19. Y. H. Kang, H. K. Min, S. M. Son, I. J. Kim & Y. K. Kim. (2007). The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Research and Clinical Practice, 77(2), 306-313. DOI : 10.1016/j.diabres.2006.11.009
  20. B. S. Suh. (2012). The association between serum gamma-glutamyltransferase within normal levels and metabolic syndrome in office workers: A 4-year follow-up study. Korean Journal of Family Medicine, 33(1), 51-58. DOI : 10.4082/kjfm.2012.33.1.51
  21. D. Z. Banderas, J. Escobedo, E. Gonzalez, M. G. Liceaga, J. C. Ramirez & M. G. Castro. (2012). γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. European Journal of Gastroenterology & Hepatology, 24(7), 805-810. DOI : 10.1097/MEG.0b013e328354044a
  22. R. A. DeFronzo & E. Ferrannini. (1991). Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14(3), 173-194. DOI :10.2337/diacare.14.3.173
  23. G. Marchesini & G. Forlani. (2002). NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology, 35(2), 497-499. DOI : 10.1053/jhep.2002.31551
  24. G. Erkan, I. Sayin, F. B. Polat, A. Corakci, G. K. Atac & H. Degertekin. (2014). The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study. Turkish Journal of Gastroenterology, 25(Suppl 1), 63-68. DOI : 10.5152/tjg.2014.6233
  25. K. Lee & J. H. Yang. (2013). Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea National Health and Nutrition Examination Survey, 2010. Metabolic Syndrome and Related Disorders, 11(4), 229-235. DOI : 10.1089/met.2012.0153
  26. World Health Organization. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia.
  27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). The Journal of the American Medical Association, 285(19), 2486-2497. DOI : 10.1001/jama.285.19.2486
  28. D. S. Lee et al. (2007). Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(1), 127-133. DOI : 10.1161/01.ATV.0000251993.20372.40
  29. Y. Xu et al. (2011). Cross-sectional and longitudinal association of serum alanine aminotransaminase and γ-glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese people. Journal of Diabetes, 3(1), 38-47. DOI : 10.1111/j.1753-0407.2010.00111.x
  30. A. C. Hwang, Y. C. Lin, P. T. Liu, Y. M. Kao & J. D. Chen. (2012). Synergistic effect of gamma glutamyltransferase and obesity on metabolic syndrome, independent of hepatic steatosis. Annals of Epidemiology, 22(12), 876-880. DOI : 10.1016/j.annepidem.2012.09.012
  31. M. Y. Lee et al. (2008). Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population. Diabetic Medicine, 25(4), 469-475. DOI : 10.1111/j.1464-5491.2008.02415.x
  32. O. Niemela. (2016). Biomarker-Based Approaches for Assessing Alcohol Use Disorders. International Journal of Environmental Research and Public Health, 13(2), 166. DOI : 10.3390/ijerph13020166
  33. K. A. Shin. (2019). Comparison of the serum gamma-glutamyl transferase and serum uric acid levels according to the obesity types based upon on the body mass index in Korean men. Korean Journal of Clinical Laboratory Science, 51(1), 50-56. DOI : 10.15324/kjcls.2019.51.1.50
  34. M. Penke, W. Kiess & T. Giorgis. (2016). Non-alcoholic fatty liver disease in children and adolescents. Journal of Pediatric Endocrinology and Metabolism, 29(12), 1329-1330. DOI : 10.1515/jpem-2016-0415
  35. M. Boyraz et al. (2014). Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria. Obesity Research and Clinical Practice, 8(4), e356-e363. DOI : 10.1016/j.orcp.2013.08.003
  36. M. Tiikkainen et al. (2002). Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obesity Research, 10(9), 859-867. DOI : 10.1038/oby.2002.118
  37. M. Adiels et al. (2006). Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia, 49(4), 755-765. DOI : 10.1007/s00125-005-0125-z
  38. D. H. Lee, R. Blomhoff & D. R. Jacobs. (2004). Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radical Research, 38(6), 535-539. DOI : 10.1080/10715760410001694026
  39. P. M. Ridker, P. W. F. Wilson & S. M. Grundy. (2004). Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation, 109(23), 2818-2825. DOI : 10.1161/01.CIR.0000132467.45278.59
  40. A. Kerner et al. (2005). Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(1), 193-197. DOI : 10.1161/01.ATV.0000148324.63685.6a
  41. J. M. Park, J. Y. Lee, D. C. Lee & Y. J. Lee. (2017). Serum γ-glutamyltransferase level and metabolic syndrome in children and adolescents: Korean National Health and Nutrition Examination Survey. Journal of Diabetes Investigation, 9(3), 522-528. DOI : 10.1111/jdi.12716
  42. B. Kasapoglu, C. Turkay, Y. Bayram & C. Koca. (2010). Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey. Indian Journal of Medical Research, 132, 56-61.
  43. K. Lee, J. Han & S. G. Kim. (2014). Increasing risk of diabetes mellitus according to liver function alterations in electronic workers. Journal of Diabetes Investigation, 5(6), 671-676. DOI : 10.1111/jdi.12202
  44. S. Lee et al. (2015). Serum gamma-glutamyltransferase levels are associated with concomitant cardiovascular risk factors in Korean hypertensive patients: A nationwide population-based study. Medicine (Baltimore), 94(50), e2171. DOI : 10.1097/MD.0000000000002171